36-Month Post Marketing Surveillance and Analysis of Menactra in 2-10 Year Olds.

Trial Profile

36-Month Post Marketing Surveillance and Analysis of Menactra in 2-10 Year Olds.

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Feb 2015

At a glance

  • Drugs Meningococcal vaccine groups A C Y W-135 conjugate (Primary)
  • Indications Meningococcal group A infections; Meningococcal group C infections; Meningococcal group W-135 infections; Meningococcal group Y infections; Meningococcal infections
  • Focus Adverse reactions
  • Sponsors Sanofi; sanofi pasteur
  • Most Recent Events

    • 11 Feb 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 22 Apr 2013 Planned End Date changed from 1 Nov 2013 to 1 May 2014 as reported by ClinicalTrials.gov.
    • 28 Mar 2013 Planned end date changed from 1 Nov 2012 to 1 Nov 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top